PAVmed (PAVM) Operating Leases (2022 - 2025)

PAVmed's Operating Leases history runs 4 years deep, the most recent figure standing at $2.2 million for Q4 2025.

• On a quarterly basis, Operating Leases fell 18.55% year-over-year to $2.2 million in Q4 2025; TTM through Dec 2025 was $2.2 million, a 18.55% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 18.55% from the prior year.
• Operating Leases rose to $2.2 million in Q4 2025 per PAVM's latest filing, from $1.8 million in the prior quarter.
• Across five years, Operating Leases topped out at $5.2 million in Q1 2023 and bottomed at $1.8 million in Q3 2025.
• The 4-year median for Operating Leases is $3.0 million (2022), against an average of $3.3 million.
• Across the five-year window, Operating Leases soared 74.44% in 2023 and tumbled 46.2% in 2025, its largest moves.
• Year by year, Operating Leases stood at $3.0 million in 2022, then soared by 51.49% to $4.5 million in 2023, then slumped by 39.01% to $2.8 million in 2024, then declined by 18.55% to $2.2 million in 2025.
• Per Business Quant, the three latest PAVM Operating Leases figures stand at $2.2 million (Q4 2025), $1.8 million (Q3 2025), and $2.5 million (Q2 2025).